Global Seroprevalence of Tickborne Lyme Disease About 14.5%
The reported estimated global seroprevalence of Borrelia burgdorferi sensu lato (Bb) is 14.5%.
The reported estimated global seroprevalence of Borrelia burgdorferi sensu lato (Bb) is 14.5%.
The CDC has released a toolkit to help individuals protect themselves against Lyme and other tickborne diseases.
An antiviral that targets all the Herpes family virus successfully treated a patient with CFS.